...

Sita-Met 50/500 Specification

Requires Prescription (YES/NO): Yes

Generics: Sitagliptin + Metformin Hydrochloride

Used For: Type 2 Diabetes Mellitus (blood sugar control)

Class: DPP-4 Inhibitor + Biguanide (Antidiabetic Combination)


🔍 How It Works

  • Sitagliptin: A DPP-4 inhibitor that increases levels of incretin hormones. These hormones stimulate insulin release and reduce glucagon levels in response to meals, thereby lowering blood sugar.

  • Metformin: A biguanide that decreases glucose production in the liver, increases insulin sensitivity, and improves glucose uptake by muscles.

Together, they help achieve better blood sugar control in patients with type 2 diabetes, especially when diet, exercise, or single therapy is insufficient.

Usage and Safety

Dosage (general guidance – doctor decides exact dose):

  • Typical starting dose: 1 tablet (50mg Sitagliptin / 500mg Metformin) twice daily with meals.

  • Dose may be adjusted based on blood sugar levels and tolerance.

  • Always follow your doctor’s prescription.

Side Effects:

  • Common: Nausea, diarrhea, stomach upset, headache, upper respiratory infections.

  • Serious (seek medical help):

    • Lactic acidosis (rare but serious with Metformin)

    • Severe allergic reactions (rash, swelling, difficulty breathing)

    • Pancreatitis (abdominal pain, nausea, vomiting)

Drug Interactions:

  • Alcohol → ↑ risk of lactic acidosis.

  • Strong diuretics or ACE inhibitors → ↑ kidney problems.

  • Other diabetes medicines (insulin, sulfonylureas) → ↑ risk of low blood sugar.

  • Corticosteroids, thyroid hormones → may increase blood sugar.


🩺 Indication

Sita-Met is prescribed for:

  • Management of Type 2 Diabetes Mellitus

  • Patients uncontrolled on metformin or sitagliptin alone

  • Patients requiring dual therapy to improve glycemic control


🚫 When Not to Use

Do not use Sita-Met if you have:

  • Allergy to sitagliptin, metformin, or any component.

  • Type 1 diabetes or diabetic ketoacidosis (DKA).

  • Severe kidney impairment (eGFR < 30 ml/min/1.73m²).

  • Metabolic acidosis, including lactic acidosis.

  • Severe liver disease, alcohol abuse, or heart failure (risk of lactic acidosis).

⚠️ Precautions

  • Monitor kidney function regularly (before starting and during treatment).

  • Take with meals to reduce stomach upset.

  • Avoid excessive alcohol consumption.

  • Inform your doctor before surgery or X-ray with contrast dye (metformin should be stopped temporarily).

  • Not a substitute for diet and exercise.

⚠️ Warnings

  • Warning 1: Risk of lactic acidosis with metformin (rare but serious).

  • Warning 2: May cause acute pancreatitis – stop and seek medical help if severe abdominal pain occurs.

  • Warning 3: Use with caution in elderly patients and those with kidney, liver, or heart disease.

Pregnancy Category

  • Category B: Limited data, use only if clearly needed.

  • Insulin is usually preferred for diabetes management in pregnancy.

  • Not recommended during breastfeeding without doctor’s advice.


 Storage

  • Store at room temperature (below 25°C).

  • Protect from moisture, heat, and direct sunlight.

  • Keep out of reach of children.